Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

The latest news from Arcinova

December 18, 2019

The expertise of the next generation and the implementation of flow chemistry in pharma

Our Head of Drug Substance, Paul Quigley, shared his insights into how the next generation of scientists are using their skills and knowledge to help bridge the gap in expertise between batch and
December 16, 2019

Ian Shott provides foreword to the ‘Engineering Biology: A Priority for Growth’ report

Our “Individuals, groups and communities working in engineering biology must get together at this important time and agree how they can build better connections and incentivise this collaboratio
October 21, 2019

WardHadaway Fastest50!

We are delighted to have been included in the Ward Hadaway #Fastest50 growing companies in the #Northeast. A huge congratulations to all participating companies! See the full list
October 20, 2019

Arcinova Fundraising Sept/Oct 2019

September 3, 2019

Arcinova appoints new CEO to continue rapid expansion

August 7, 2019

Arcinova delighted to be finalists in OBN awards!

July 25, 2019

Arcinova's Dr Stephen Byard Recieves Award For Service

July 24, 2019

Inspiring and supporting the next generation of pharma chemists

July 23, 2019

Prestigious Royal Society honour for Bristol academic




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH